BRIMONIDINE TARTRATE; BRINZOLAMIDE | ALCON LABS INC | ||
0.2%;1% | |||
Yes | Yes | ||
2030-Oct-30 | Expired | ||
None | None | ||
None | No | ||
SIMBRINZA™ is a fixed combination of a carbonic anhydrase inhibitor and an alpha 2 adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. |
0 | 1 | 0 |
Total Other Developers | 11 |
---|
Drugs with Suitability | No |
---|
0.2%;1% | ** | ** | Up | - | - |
NDA Sales Available | Total Generic Sales Available |
---|---|
Yes | 0 |
ANDA No | Generic Co | Manufacturer Name | Operations | Manufacturer Address | Country |
---|
Download GenUS Drug Report
Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023
+91 94997 68112
nimish@researchdelta.com